← brief for 2026-10-04 · Slowing decline

GLP-1 Receptor Agonists Beyond Metabolic Control: Cardiovascular Benefits, Renal Protection, Neurological Effects and Socioeconomic Implications of Widespread Use.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This review looked at 39 studies on GLP-1 drugs, which are often used for diabetes and weight loss. It found that these drugs help protect the kidneys and heart. They also seem to have effects on the brain and nervous system. This suggests the drugs do more than just lower blood sugar.

Who did this work

Weronika Wrona (Wroclaw Medical University) · Anna Wojdas · Wiktoria Wdowiak · Małgorzata Dorożalska · Małgorzata Jurczyk · Aleksandra Glapa · Hanna Ludwisiak · Maja Cwalina · Julia Owsik · Weronika Ryś

Source

Article · OpenAlex, CKD works · 2026-10-02
https://doi.org/10.12775/qs.2026.77.76169